Unveiling the Potential of 4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline CAS 190728-25-7

A vital organic intermediate powering advancements in pharmaceutical synthesis and material science.

Get a Quote & Sample

Product Advantages

High Purity and Reliability

Achieve superior results with a chemical intermediate that boasts an assay of ≥99.5%, ensuring the consistency and quality needed for sensitive pharmaceutical applications and efficient 4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline synthesis.

Versatile Building Block

As a key organic intermediate for drug development, its versatile structure facilitates the creation of diverse therapeutic agents, pushing the boundaries of medicinal chemistry.

Crucial for Targeted Therapies

Its role as a Cabozantinib intermediate highlights its significance in developing advanced treatments for serious conditions, underscoring its value in modern medicine.

Key Applications

Pharmaceutical Synthesis

This compound is primarily employed as a pharmaceutical intermediate, serving as a crucial building block for active pharmaceutical ingredients (APIs) in various drug formulations, directly supporting the pharmaceutical intermediate CAS 190728-25-7 market.

Drug Discovery Research

Its utility extends to medicinal chemistry and drug discovery, where researchers utilize it to explore new molecular entities and optimize drug candidates for enhanced efficacy.

Material Science Innovation

Beyond pharmaceuticals, its unique chemical properties lend themselves to applications in material science, potentially contributing to the development of novel functional materials.

Chemical Synthesis Pathways

The compound's role in complex chemical synthesis pathways, including its specific use in Cabozantinib intermediate production, makes it valuable for chemical manufacturers and researchers.